- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on T-cell Lymphoma (PTCL and CTCL)
Total 6877 results
-
National Cancer Institute (NCI)TerminatedUnspecified Childhood Solid Tumor, Protocol Specific | Peripheral T-cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Intraocular Lymphoma | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides... and other conditionsUnited States
-
The University of Hong KongUnknownNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin T-cell LymphomaHong Kong
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedNon-Hodgkin Lymphoma | T-Cell Lymphoma | Anaplastic Large-Cell LymphomaUnited States, Korea, Republic of, Spain, United Kingdom, Taiwan, Czechia, Hungary, France, Israel, Germany, Italy, Denmark, Australia, Poland, Romania, Canada
-
Yanyan LiuRecruiting
-
Ruijin HospitalRecruitingNK/T-cell LymphomaChina
-
Ruijin HospitalShanxi Province Cancer Hospital; The First Affiliated Hospital of Anhui Medical... and other collaboratorsRecruiting
-
International Extranodal Lymphoma Study Group (IELSG)RecruitingLymphoma, Extranodal NK-T-CellChina
-
Peking UniversityRecruitingPeripheral T-cell LymphomaChina
-
Samsung Medical CenterRecruitingPeripheral T-cell LymphomaKorea, Republic of
-
Huazhong University of Science and TechnologyPeking University People's Hospital; West China Hospital; Ruijin HospitalCompletedT-cell Lymphoma Adults
-
Ruijin HospitalActive, not recruitingPeripheral T-cell LymphomaChina
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical CenterTerminated
-
The Lymphoma Academic Research OrganisationCompletedEfficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell LymphomaPeripheral T-cell LymphomaSpain, France, Korea, Republic of, Italy, Germany, Singapore, Belgium, Portugal
-
Samsung Medical CenterCompletedNon-Hodgkin T-cell LymphomaKorea, Republic of
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States, United Kingdom, Canada, France, Italy, Belgium
-
Chipscreen Biosciences, Ltd.CompletedPeripheral T-cell LymphomaChina
-
CerRx, Inc.UnknownPeripheral T-cell LymphomaUnited States
-
Mundipharma K.K.CompletedPeripheral T-cell LymphomaJapan
-
Mingzhi ZhangZhengzhou UniversityCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Solasia Pharma K.K.Synex Consulting Korea Ltd.CompletedPeripheral T-cell LymphomaKorea, Republic of
-
Air Force Military Medical University, ChinaUnknown
-
Cancer Institute and Hospital, Chinese Academy...Peking University Cancer Hospital & Institute; The Affiliated Hospital Of Guizhou... and other collaboratorsRecruitingHigh-Risk Cancer | Early-stage | Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States, Germany, Italy
-
Sun Yat-sen UniversityRecruitingExtranodal Natural Killer T Cell LymphomaChina
-
Ono Pharmaceutical Co. LtdRecruitingRelapsed or Refractory T Cell LymphomaUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedPeripheral T Cell Lymphoma | Treatment-naïveChina
-
Aileron Therapeutics, Inc.CompletedLymphoma | Solid Tumor | Peripheral T-Cell LymphomaUnited States
-
Fundació Institut de Recerca de l'Hospital de la...Instituto de Salud Carlos III; Josep Carreras Leukaemia Research InstituteRecruitingHodgkin Lymphoma, Adult | T Cell LymphomaSpain
-
Walter HanelActive, not recruitingRecurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Anaplastic Large Cell Lymphoma | T-Cell Non-Hodgkin Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin... and other conditionsUnited States
-
Canadian Cancer Trials GroupCelgeneCompletedDiffuse Large B-Cell Lymphoma | Peripheral T-Cell LymphomaCanada
-
University of CologneUnknownCD30 Positive Cutaneous T Cell Lymphoma | CD30 Positive Transformed Mycosis FungoidesGermany
-
Affimed GmbHArtiva Biotherapeutics, Inc.RecruitingPeripheral T Cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaUnited States
-
Bristol-Myers SquibbRecruitingPeripheral T-cell LymphomaJapan
-
Henan Cancer HospitalNot yet recruitingPeripheral T Cell LymphomaChina
-
Tianjin Medical University Cancer Institute and...CSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruiting
-
Peking Union Medical College HospitalCSPC Ouyi Pharmaceutical Co., Ltd.RecruitingPeripheral T-cell Lymphoma | TreatmentChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingPeripheral T Cell LymphomaChina
-
Sun Yat-sen UniversityRecruitingNatural Killer T-cell LymphomaChina
-
Seagen Inc.Active, not recruitingPeripheral T-cell LymphomaUnited States, Czechia, Italy, Spain, United Kingdom, France
-
SecuraBioCompletedPeripheral T-cell LymphomaUnited States, United Kingdom, Germany, Italy
-
AkesoAkeso Pharmaceuticals, Inc.TerminatedPeripheral T-cell LymphomaChina
-
Spectrum Pharmaceuticals, IncTerminatedPeripheral T-cell LymphomaBelgium, Spain, United States, Australia, France, Israel, Canada, United Kingdom, New Zealand, Italy, Ireland, Poland, Puerto Rico
-
Fondazione Italiana Linfomi ONLUSCompletedPeripheral T-cell LymphomaItaly
-
Peking UniversityUnknown
-
Lymphoma Study AssociationJanssen-Cilag International NVCompletedPeripheral T-cell LymphomaFrance, Belgium
-
Southwest Hospital, ChinaUnknownPeripheral T-cell Lymphoma
-
Solasia Pharma K.K.CompletedPeripheral T-cell LymphomaJapan